Skip to main content
. 2020 Feb;9(1):43–50. doi: 10.21037/tp.2019.12.03

Figure 3.

Figure 3

Survival of sequenced patients. (A) Event free survival comparing Ras aberrant (red) to non-Ras aberrant (blue); (B) overall survival of Ras aberrant (red) and non-Ras aberrant (blue) patients; (C) overall survival of ALL patients with mutations predictive of Ras aberrancy (red) or non-Ras aberrant (blue). *, P<0.05. ALL, acute lymphoblastic leukemia.